BioCatalystWatch
LONAWorkspace / LONA / OverviewCompany library
Price
Market cap
Next catalystExpected 2026Lasofoxifene — ELAINE-3 with abemaciclib · Enrollment completionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Lasofoxifene

Estrogen receptor (ESR1)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Lasofoxifene

Estrogen receptor (ESR1)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

ATH-1020

MET

PreINDP1P2P3FilingApproved

ATH-1020

MET

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

ATH-1020

MET

PreINDP1P2P3FilingApproved
Brelgometon (ATH-1105)

MET (HGF receptor)

Upcoming / outlook

  • Timing and evidence

NDX-1017

MET (HGF receptor)

PreINDP1P2P3FilingApproved

History / paused

MET (HGF receptor)

PreINDP1P2P3FilingApproved

MET (HGF receptor)

PreINDP1P2P3FilingApproved

MET

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

LONA PR & News

PR & News

LONA SEC archive